Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies

Overview

Journal Neurology

Specialty Neurology

Date 2023 Feb 7

PMID 36750385

Authors

Alice M Donnan

Amy L Schneider

Sophie Russ-Hall

Leonid Churilov

Ingrid E Scheffer

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: The genetic developmental and epileptic encephalopathies (DEEs) comprise a large group of severe epilepsy syndromes, with a wide phenotypic spectrum. Currently, the rates of convulsive status epilepticus (CSE), nonconvulsive status epilepticus (NCSE), and sudden unexplained death in epilepsy (SUDEP) in these diseases are not well understood. We aimed to describe the proportions of patients with frequently observed genetic DEEs who developed CSE, NCSE, mortality, and SUDEP. Understanding the risks of these serious presentations in each genetic DEE will enable earlier diagnosis and appropriate management.

Methods: In this retrospective analysis of patients with a genetic DEE, we estimated the proportions with CSE, NCSE, and SUDEP and the overall and SUDEP-specific mortality rates for each genetic diagnosis. We included patients with a pathogenic variant in the genes , , , , , , , , , , and and with Angelman syndrome (AS).

Results: The cohort comprised 510 individuals with a genetic DEE, in whom we observed CSE in 47% and NCSE in 19%. The highest proportion of CSE occurred in patients with -associated DEEs, including 181/203 (89%; 95% CI 84-93) patients with Dravet syndrome and 8/15 (53%; 95% CI 27-79) non-Dravet -DEEs. CSE was also notable in patients with pathogenic variants in (6/10; 60%; 95% CI 26-88) and (8/15; 53%; 95% CI 27-79). NCSE was common in patients with non-Dravet -DEEs (8/15; 53%; 95% CI 27-79) and was notable in patients with -DEEs (6/14; 43%; 95% CI 18-71) and AS (6/19; 32%; 95% CI 13-57). There were 42/510 (8%) deaths among the cohort, producing a mortality rate of 6.1 per 1,000 person-years (95% CI 4.4-8.3). Cases of SUDEP accounted for 19/42 (48%) deaths. Four genes were associated with SUDEP: , , , and The estimated SUDEP rate was 2.8 per 1,000 person-years (95% CI 1.6-4.3).

Discussion: We showed that proportions of patients with CSE, NCSE, and SUDEP differ for commonly encountered genetic DEEs. The estimates for each genetic DEE studied will inform early diagnosis and management of status epilepticus and SUDEP and inform disease-specific counseling for patients and families in this high-risk group of conditions.

Citing Articles

Expert-Agreed Practical Recommendations on the Use of Fenfluramine in Developmental and Epileptic Encephalopathies Based on Clinical Experience and Literature Review.

Villanueva V, Soto-Insuga V, Smeyers P, Aledo-Serrano A, Sanchez-Carpintero R, Garcia-Penas J Neurol Ther. 2025; 14(2):447-465.

PMID: 39988625 PMC: 11906945. DOI: 10.1007/s40120-025-00713-1.

Adult phenotypes of genetic developmental and epileptic encephalopathies.

Vakrinou A, Pagni S, Mills J, Clayton L, Balestrini S, Sisodiya S Brain Commun. 2025; 7(1):fcaf028.

PMID: 39882024 PMC: 11775618. DOI: 10.1093/braincomms/fcaf028.

Interneuron FGF13 regulates seizure susceptibility via a sodium channel-independent mechanism.

Lin S, Gade A, Wang H, Niemeyer J, Galante A, Distefano I Elife. 2025; 13.

PMID: 39773461 PMC: 11709433. DOI: 10.7554/eLife.98661.

Plural molecular and cellular mechanisms of pore domain encephalopathy.

Abreo T, Thompson E, Madabushi A, Park K, Soh H, Varghese N Elife. 2025; 13.

PMID: 39761077 PMC: 11703504. DOI: 10.7554/eLife.91204.

National survey on the prevalence of single-gene aetiologies for genetic developmental and epileptic encephalopathies in Italy.

Mei D, Balestrini S, Parrini E, Gambardella A, Annesi G, De Giorgis V J Med Genet. 2024; 62(1):25-31.

PMID: 39613335 PMC: 11877070. DOI: 10.1136/jmg-2024-110328.

References

McTague A, Howell K, Cross J, Kurian M, Scheffer I . The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol. 2015; 15(3):304-16. DOI: 10.1016/S1474-4422(15)00250-1. View

Valente K, Koiffmann C, Fridman C, Varella M, Kok F, Andrade J . Epilepsy in patients with angelman syndrome caused by deletion of the chromosome 15q11-13. Arch Neurol. 2006; 63(1):122-8. DOI: 10.1001/archneur.63.1.122. View

Kong W, Zhang Y, Gao Y, Liu X, Gao K, Xie H . SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability. Epilepsia. 2015; 56(3):431-8. DOI: 10.1111/epi.12925. View

Abdel-Mannan O, Taylor H, Donner E, Sutcliffe A . A systematic review of sudden unexpected death in epilepsy (SUDEP) in childhood. Epilepsy Behav. 2018; 90:99-106. DOI: 10.1016/j.yebeh.2018.11.006. View

Li W, Schneider A, Scheffer I . Defining Dravet syndrome: An essential pre-requisite for precision medicine trials. Epilepsia. 2021; 62(9):2205-2217. PMC: 9291974. DOI: 10.1111/epi.17015. View

Chin R, Neville B, Peckham C, Bedford H, Wade A, Scott R . Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006; 368(9531):222-9. DOI: 10.1016/S0140-6736(06)69043-0. View

Ryvlin P, Nashef L, Lhatoo S, Bateman L, Bird J, Bleasel A . Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study. Lancet Neurol. 2013; 12(10):966-77. DOI: 10.1016/S1474-4422(13)70214-X. View

Kuchenbuch M, Barcia G, Chemaly N, Carme E, Roubertie A, Gibaud M . KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP. Brain. 2019; 142(10):2996-3008. DOI: 10.1093/brain/awz240. View

Bonardi C, Heyne H, Fiannacca M, Fitzgerald M, Gardella E, Gunning B . KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum. Brain. 2021; 144(12):3635-3650. DOI: 10.1093/brain/awab219. View

10.

Berecki G, Bryson A, Terhag J, Maljevic S, Gazina E, Hill S . SCN1A gain of function in early infantile encephalopathy. Ann Neurol. 2019; 85(4):514-525. DOI: 10.1002/ana.25438. View

11.

Sadleir L, Mountier E, Gill D, Davis S, Joshi C, DeVile C . Not all epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotype. Neurology. 2017; 89(10):1035-1042. PMC: 5589790. DOI: 10.1212/WNL.0000000000004331. View

12.

Vlaskamp D, Shaw B, Burgess R, Mei D, Montomoli M, Xie H . encephalopathy: A distinctive generalized developmental and epileptic encephalopathy. Neurology. 2018; 92(2):e96-e107. PMC: 6340340. DOI: 10.1212/WNL.0000000000006729. View

13.

Kolc K, Sadleir L, Scheffer I, Ivancevic A, Roberts R, Pham D . A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity. Mol Psychiatry. 2018; 24(2):241-251. PMC: 6344372. DOI: 10.1038/s41380-018-0066-9. View

14.

Clayton-Smith J, Laan L . Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet. 2003; 40(2):87-95. PMC: 1735357. DOI: 10.1136/jmg.40.2.87. View

15.

Myers K, McMahon J, Mandelstam S, MacKay M, Kalnins R, Leventer R . Fatal Cerebral Edema With Status Epilepticus in Children With Dravet Syndrome: Report of 5 Cases. Pediatrics. 2017; 139(4). DOI: 10.1542/peds.2016-1933. View

16.

Trinka E, Cock H, Hesdorffer D, Rossetti A, Scheffer I, Shinnar S . A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015; 56(10):1515-23. DOI: 10.1111/epi.13121. View

17.

Keller A, Whitney R, Li S, Pollanen M, Donner E . Incidence of sudden unexpected death in epilepsy in children is similar to adults. Neurology. 2018; 91(2):e107-e111. DOI: 10.1212/WNL.0000000000005762. View

18.

Burgess R, Wang S, McTague A, Boysen K, Yang X, Zeng Q . The Genetic Landscape of Epilepsy of Infancy with Migrating Focal Seizures. Ann Neurol. 2019; 86(6):821-831. PMC: 7423163. DOI: 10.1002/ana.25619. View

19.

Singh R, Andermann E, Whitehouse W, Harvey A, Keene D, Seni M . Severe myoclonic epilepsy of infancy: extended spectrum of GEFS+?. Epilepsia. 2001; 42(7):837-44. DOI: 10.1046/j.1528-1157.2001.042007837.x. View

20.

Symonds J, Zuberi S, Stewart K, McLellan A, ORegan M, MacLeod S . Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain. 2019; 142(8):2303-2318. PMC: 6658850. DOI: 10.1093/brain/awz195. View